Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T R Pisanic

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
The Analyst|April 29, 2014
Quantum dots in diagnostics and detection: principles and paradigmsT R Pisanic, Y Zhang, T H Wang
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 9, 2018
Phase II study of nab-paclitaxel in refractory small bowel adenocarcinoma and CpG island methylator phenotype (CIMP)-high colorectal cancerM J Overman, L Adam, K Raghav, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 26, 2017
Phase II study of nab-paclitaxel in refractory small bowel adenocarcinoma and CpG island methylator phenotype (CIMP)-high colorectal cancerM J Overman, L Adam, K Raghav, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
The Analyst|April 29, 2014
Quantum dots in diagnostics and detection: principles and paradigmsT R Pisanic, Y Zhang, T H Wang
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 9, 2018
Phase II study of nab-paclitaxel in refractory small bowel adenocarcinoma and CpG island methylator phenotype (CIMP)-high colorectal cancerM J Overman, L Adam, K Raghav, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 26, 2017
Phase II study of nab-paclitaxel in refractory small bowel adenocarcinoma and CpG island methylator phenotype (CIMP)-high colorectal cancerM J Overman, L Adam, K Raghav, et al.
Pageof 1